Bruna FRIZON Frizon Greggianin

Prof. Dr. Bruna FRIZON Frizon Greggianin

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2022 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
FMFernanda C. Milanesi
Fernanda C. Milanesi
BGBruna FRIZON Frizon Greggianin
Bruna FRIZON Frizon Greggianin
GSGabriela O. dos Santos
Gabriela O. dos Santos
MTMirian P. Toniazzo
Mirian P. Toniazzo
PWPatricia Weidlich
Patricia Weidlich
RORui V. Oppermann
Rui V. Oppermann

15 February 2023 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
BGBruna FRIZON Frizon Greggianin
Bruna FRIZON Frizon Greggianin
AMAna Elizia M Marques
Ana Elizia M Marques
AAAngélica A Amato
Angélica A Amato
CLCaroline L de Lima
Caroline L de Lima

21 August 2023 in International Journal of Dental Hygiene
Verified
Journal Article
Closed access
CACamilla Vieira Arruda
Camilla Vieira Arruda
IGIsa Juliane Guilardi
Isa Juliane Guilardi
LPLudmila Madeira Cardoso Pavan
Ludmila Madeira Cardoso Pavan
BGBruna FRIZON Frizon Greggianin
Bruna FRIZON Frizon Greggianin

1 January 2026 in International Journal of Dentistry
Verified
Journal Article
Open access
ATAna Júlia Martins Targino
Ana Júlia Martins Targino
JVJosy Lorena Peres da Silva Vilarinho
Josy Lorena Peres da Silva Vilarinho
VCValéria Martins de Araújo Carneiro
Valéria Martins de Araújo Carneiro
BGBruna FRIZON Frizon Greggianin
Bruna FRIZON Frizon Greggianin
MGMaria Do Carmo Machado Guimarães
Maria Do Carmo Machado Guimarães
Background: Periodontal disease, although widely documented, remains one of the leading causes of tooth loss worldwide. This situation can be attributed to patients’ difficulty in following treatment protocols and to an incomplete understanding of the disease’s mechanisms, which could be explored to develop new therapies. Objective: The present study aimed to summarize the main advances in understanding the periodontal microbiome, especially concerning the development of genetic sequencing technologies and metabolite analysis, as well as new treatment methods that have emerged from these innovations. Methods: A narrative literature review was conducted through searches in the PubMed, Scopus, Web of Science, and SciELO databases, prioritizing publications from the past 15 years while also including classic and foundational studies relevant to the theoretical framework. Conclusions: Periodontal microbiome results from the synergistic interaction among different microorganisms, rather than just the sum of their individual metabolites. This synergy can create structural microarrangements that resist biofilm disruption, such as fungal barriers surrounding Gram‐negative bacteria. Innovative treatments—such as host response modulation with resolvins and oral microbiome modulation, particularly using prebiotics derived from plant extracts (nitrate metabolism)—offer promising prospects. However, limitations remain regarding their clinical use and the challenge of managing refractory cases, highlighting the need for further research to support these findings.

1 January 2026 in Journal of Applied Oral Science
Verified
Journal Article
Open access
MRMaria Eduarda Oliveira Rodrigues
Maria Eduarda Oliveira Rodrigues
JVJosy Lorena Peres da Silva Vilarinho
Josy Lorena Peres da Silva Vilarinho
JCJoão Gabriel Jucá Chermont
João Gabriel Jucá Chermont
CSCRISTINE MIRON STEFANI
CRISTINE MIRON STEFANI
VCValéria Martins de Araújo Carneiro
Valéria Martins de Araújo Carneiro
BGBruna FRIZON Frizon Greggianin
Bruna FRIZON Frizon Greggianin
Objective: To investigate associations among periodontal parameters, glycated hemoglobin (HbA1c), and metabolic parameters in adults with and without type 2 diabetes mellitus (T2D). Methodology: A cross-sectional study included 74 adults diagnosed with periodontitis according to the current periodontal classification of 2018. Participants underwent a full-mouth periodontal examination, laboratory assessment, and Body Mass Index (BMI). Periodontitis was categorized into Stages I/II and Stages III/IV. HbA1c, lipid profile, high-sensitivity C-reactive protein (CRP), and insulin resistance (HOMA-IR) were assessed. Periodontal inflammatory burden was quantified using the Periodontal Inflamed Surface Area (PISA). Non-parametric tests and Spearman correlation analyses were performed, stratified by diabetes status (α=5%). Results: Individuals with advanced periodontitis (Stages III/IV) had significantly higher HbA1c levels (6.8% vs. 5.8%; p=0.007), higher triglyceride concentrations (142.0 vs. 100.5 mg/dL; p=0.016), and lower HDL-cholesterol levels (46.0 vs. 52.0 mg/dL; p=0.012) than those in Stages I/II. Poor glycemic control (HbA1c >8.5%) and T2D duration ≥10 years were significantly associated with advanced stages (p<0.05). No significant differences were observed for BMI, LDL, total cholesterol (TC), CRP, or HOMA-IR between groups. In adults with T2D, PISA correlated positively with TC and LDL-cholesterol, whereas in non-diabetic individuals, PISA was associated primarily with triglycerides. Conclusions: Advanced periodontitis was associated with poorer glycemic control and a more atherogenic lipid profile, particularly characterized by elevated triglycerides and reduced HDL-cholesterol. The findings support periodontitis as a potential marker of systemic metabolic dysregulation and reinforce the importance of integrating periodontal care into cardiometabolic risk management strategies.